Scholarlink

Background <p>This study aimed to compare perioperative outcomes between da Vinci XI and da Vinci SI or SP robotic radical prostatectomies.</p> Methods <p>The study systematically searched four databases: Embase, PubMed, Cochrane Library, and Web of Science. The search time ranged from database creation to July 2025. Statistical analysis was performed using Stata17. Effect denoted a continuous variable, whereas OR/RR denoted a binary variable, and the 95 % confidence interval (CI) was calculated.</p> Results <p>The seven included studies involved 2297 patients undergoing robotic radical prostatectomy. Compared with SP, XI had a longer hospital stay (effect, 0.91; 95 % CI 0.04–1.77; <i>P</i> &lt; 0.05). Compared with SI, XI had a lower positive margin rate (odds ratio, 0.74; 95 % CI 0.57–0.97; <i>P</i> &lt; 0.05). Operation time, estimated blood loss, overall complications, and major complications did not differ among XI, SI, and SP.</p> Conclusion <p>Compared with SP, XI’s hospital stay appeared to be longer. Compared with SI, XI seemed to have a lower positive surgical margin. However, more research is needed to determine differences in oncology outcomes and cost-effectiveness among several robotic surgical platforms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparison of Perioperative Outcomes Between da Vinci XI and da Vinci SI/SP Robotic Radical Prostatectomies: A Meta-Analysis of Comparative Studies

  • 期刊论文

  • 发表日期：

    2025年10月14日

查看全文
  • Si Ge,
  • Zhiqiang Zeng,
  • Lei Zheng,
  • Jiakai Ma,
  • Deyu Wang,
  • Yuan Ren

摘要

Background

This study aimed to compare perioperative outcomes between da Vinci XI and da Vinci SI or SP robotic radical prostatectomies.

Methods

The study systematically searched four databases: Embase, PubMed, Cochrane Library, and Web of Science. The search time ranged from database creation to July 2025. Statistical analysis was performed using Stata17. Effect denoted a continuous variable, whereas OR/RR denoted a binary variable, and the 95 % confidence interval (CI) was calculated.

Results

The seven included studies involved 2297 patients undergoing robotic radical prostatectomy. Compared with SP, XI had a longer hospital stay (effect, 0.91; 95 % CI 0.04–1.77; P < 0.05). Compared with SI, XI had a lower positive margin rate (odds ratio, 0.74; 95 % CI 0.57–0.97; P < 0.05). Operation time, estimated blood loss, overall complications, and major complications did not differ among XI, SI, and SP.

Conclusion

Compared with SP, XI’s hospital stay appeared to be longer. Compared with SI, XI seemed to have a lower positive surgical margin. However, more research is needed to determine differences in oncology outcomes and cost-effectiveness among several robotic surgical platforms.